<DOC>
	<DOCNO>NCT02680769</DOCNO>
	<brief_summary>Magnesium ( Mg ) involve several pathway could affect chronic obstructive pulmonary disease ( COPDs ) , namely contractility excitability neuro-muscolar endothelial cell low-grade inflammation , typical state COPD . In sense , several randomize control trial ( RCTs ) confirm positive role Mg asthma since long-period oral supplementation Mg lead clinical spirometric improvement . Subjects COPD seem reduce bioavailability Mg probably due use drug may increase Mg loss ( e.g . beta-agonists cortisone ) , reduce dietary Mg intake , heavy smoking . A recent study show administration endovenous aerosol Mg sulphate beta-agonists acutely improve maximum expiratory flow COPD relapse well prolonged treatment endovenous sulphate Mg lead reduction pulmonary hyperinflation increase muscle involve respiration , consequent clinical instrumental improvement . These evidence suggest chronic supplementation Mg could improve COPD clinical instrumental parameter , , best knowledge , study available sense .</brief_summary>
	<brief_title>Effect Magnesium Supplementation COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Adults ( &gt; 18 year ) . Moderatesevere COPD ( FEV1 3080 % theorical value ) . Already take magnesium calcium supplementation . Severe renal ( creatinine clearance &lt; 30 ml/min ) hepatic decline presence comorbidities interfere outcome ( e.g . dementia ) . Hypermagnesemia ( serum Mg &gt; 1.85 mmol/L ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>